Apr
03
2008
News | Posted by Anonymous
Halifax Biomedical to Expand Sales
A homegrown, innovative biomedical enterprise in rural Cape Breton is about to expand its operations, creating jobs and increasing export sales.
Mar
17
2008
News | Posted by Anonymous
Innovacorp Welcomes Skillz Systems
The staff and clients of Innovacorp welcome our newest client, Skillz Systems.
Mar
17
2008
News | Posted by Anonymous
Innovacorp Joins Globe & Mail Expert Panel
Innovacorp’s president and CEO is now lending his business expertise to companies across the country, advising them on how they can enhance their operations and strategies.
Mar
14
2008
News | Posted by Anonymous
Innovacorp Welcomes Clearly Health
The staff and clients of Innovacorp welcome our newest client, Clearly Health.
Mar
10
2008
News | Posted by Anonymous
Innovacorp Proud Sponsor of Acadia Challenge
Innovacorp is a proud sponsor of this year’s Acadia Challenge Proof of Concept competition.
Mar
03
2008
News | Posted by Anonymous
Innovacorp Welcomes Marsco Technologies
The staff and clients of Innovacorp welcome our newest client, Marsco Technologies.
Feb
20
2008
News | Posted by Anonymous
IVT Appoints the Honourable Michael Kirby as Chair
ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, announced today the appointment of former senator, Michael Kirby, as the new board of directors chair. Michael Kirby succeeds the late Dr. Warrick Kimmins, who provided exemplary leadership during his tenure and was instrumental in spinning out IVT’s novel technology from Dalhousie University.
Feb
12
2008
News | Posted by Anonymous
I-3 Competition Provincial Winner: MorSwift Machines Inc.
An intense five-month competition came to an end Tuesday evening as Innovacorp announced the provincial winner of the I-3 Technology Start-Up Competition. MorSwift Machines Inc. from Digby NS, was awarded a $100,000 seed equity investment from Innovacorp.
Feb
12
2008
News | Posted by Anonymous
Images from Innovacorp's I-3 Competition Awards Event
Check out some images from Innovacorp's I-3 Technology Start-Up Competition awards event - February 12, 2008.
Jan
23
2008
News | Posted by Anonymous
IVT Discusses Phase I Clinical Trial Application
ImmunoVaccine Technologies Inc. (IVT) announced today that it has met with Health Canada’s regulatory affairs division, the Biologics and Genetic Therapies Directorate, to discuss requirements for a Phase I clinical trial application. For Phase I human clinical trials, IVT plans to combine novel antigens with its vaccine-enhancement technology, the VacciMax® platform.
